Raymond James & Associates Johnson & Johnson Transaction History

Raymond James & Associates

$146 Billion
Q1 2024

A detailed history of Raymond James & Associates transactions in Johnson & Johnson stock. As of the latest transaction made, Raymond James & Associates holds 6,384,341 shares of JNJ stock, worth $940 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

6,384,341

Previous 6,061,707 5.32%

Holding current value

$940 Million

Previous $950 Million 6.3%

% of portfolio

0.69%

Previous 0.72%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$155.22 - $162.74 $50.1 Million - $52.5 Million	322,634 Added 5.32%	6,384,341 $1.01 Billion
Q4 2023 Jan 16, 2024	BUY	$145.6 - $158.88 $3.93 Million - $4.29 Million	26,982 Added 0.45%	6,061,707 $950 Million
Q3 2023 Oct 24, 2023	SELL	$155.75 - $174.48 $29.2 Million - $32.7 Million	-187,448 Reduced 3.01%	6,034,725 $940 Million
Q2 2023 Jul 25, 2023	BUY	$154.35 - $166.11 $20.5 Million - $22 Million	132,557 Added 2.18%	6,222,173 $1.03 Billion
Q1 2023 Apr 14, 2023	BUY	$151.05 - $180.26 $39.6 Million - $47.2 Million	261,975 Added 4.5%	6,089,616 $944 Million

Q4 2022 Feb 08, 2023	BUY	$160.2 - $179.79 $57.6 Million - $64.7 Million	359,785 Added 6.58%	5,827,641 $1.03 Billion
Q3 2022 Oct 25, 2022	BUY	$161.33 - $179.52 $17.4 Million - $19.3 Million	107,613 Added 2.01%	5,467,856 $893 Million
Q2 2022 Aug 12, 2022	BUY	$168.19 - $186.01 $17.9 Million - $19.8 Million	106,194 Added 2.02%	5,360,243 $952 Million
Q1 2022 May 11, 2022	BUY	$158.14 - $179.59 $5.64 Million - $6.4 Million	35,642 Added 0.68%	5,254,049 $931 Million
Q4 2021 Feb 08, 2022	BUY	$155.93 - $173.01 $18.5 Million - $20.5 Million	118,759 Added 2.33%	5,218,407 $893 Million
Q3 2021 Nov 02, 2021	SELL	$161.5 - $179.47 $26.2 Million - $29.1 Million	-162,116 Reduced 3.08%	5,099,648 $824 Million
Q2 2021 Aug 11, 2021	BUY	$159.48 - $171.07 $236 Million - $253 Million	1,477,064 Added 39.03%	5,261,764 $867 Million
Q1 2021 May 14, 2021	SELL	$153.07 - $170.48 $10.5 Million - $11.7 Million	-68,689 Reduced 1.78%	3,784,700 $622 Million
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $22.7 Million - $26 Million	165,219 Added 4.48%	3,853,389 $606 Million
Q3 2020 Nov 04, 2020	BUY	$140.38 - $153.83 $2.43 Million - $2.66 Million	17,275 Added 0.47%	3,688,170 $549 Million
Q2 2020 Jul 28, 2020	BUY	$128.81 - $155.51 $16.6 Million - $20 Million	128,618 Added 3.63%	3,670,895 $516 Million
Q1 2020 Apr 21, 2020	BUY	$111.14 - $153.99 $3.66 Million - $5.07 Million	32,908 Added 0.94%	3,542,277 $465 Million
Q4 2019 Feb 12, 2020	BUY	$127.5 - $146.44 $36.8 Million - $42.3 Million	288,665 Added 8.96%	3,509,369 $512 Million
Q3 2019 Nov 07, 2019	SELL	$126.95 - $142.14 $18.8 Million - $21 Million	-147,789 Reduced 4.39%	3,220,704 $417 Million
Q2 2019 Aug 06, 2019	BUY	$131.15 - $144.24 $4.46 Million - $4.9 Million	33,985 Added 1.02%	3,368,493 $469 Million
Q1 2019 May 06, 2019	SELL	$125.72 - $139.79 $26.1 Million - $29 Million	-207,640 Reduced 5.86%	3,334,508 $466 Million
Q4 2018 Feb 11, 2019	BUY	$122.84 - $147.84 $12.6 Million - $15.1 Million	102,193 Added 2.97%	3,542,148 $457 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $20.2 Million - $23.8 Million	166,366 Added 5.08%	3,439,955 $475 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $21.7 Million - $23.9 Million	181,560 Added 5.87%	3,273,589 $397 Million
Q1 2018 May 14, 2018	BUY	$125.1 - $148.14 $30.6 Million - $36.2 Million	244,662 Added 8.59%	3,092,029 $396 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $17.2 Million - $18.9 Million	131,429 Added 4.84%	2,847,367 $398 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $9.36 Million - $9.79 Million	72,286 Added 2.73%	2,715,938 $353 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,643,652	2,643,652 $350 Million

Others Institutions Holding JNJ

# of Institutions

4,144

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $385B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Johnson & Johnson Transaction History